EP3262168 - HOST CELL PROTEIN MODIFICATION [Right-click to bookmark this link] | Status | Patent revoked Status updated on 19.03.2021 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 19.07.2019 | ||
Former | Grant of patent is intended Status updated on 31.01.2019 | ||
Former | Examination is in progress Status updated on 01.06.2018 | ||
Former | Request for examination was made Status updated on 01.12.2017 | ||
Former | The international publication has been made Status updated on 15.08.2017 | Most recent event Tooltip | 20.06.2024 | Lapse of the patent in a contracting state New state(s): CY | published on 24.07.2024 [2024/30] | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2019/34] |
Former [2018/01] | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | Inventor(s) | 01 /
BURAKOV, Darya c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591 / US | 02 /
GOREN, Michael c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591 / US | 03 /
CHEN, Gang c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, New York 10591 / US | [2018/01] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2019/34] |
Former [2018/01] | J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 16710378.7 | 26.02.2016 | [2018/01] | WO2016US19915 | Priority number, date | US201562126213P | 27.02.2015 Original published format: US 201562126213 P | US201662298869P | 23.02.2016 Original published format: US 201662298869 P | [2018/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016138467 | Date: | 01.09.2016 | Language: | EN | [2016/35] | Type: | A1 Application with search report | No.: | EP3262168 | Date: | 03.01.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.09.2016 takes the place of the publication of the European patent application. | [2018/01] | Type: | B1 Patent specification | No.: | EP3262168 | Date: | 21.08.2019 | Language: | EN | [2019/34] | Search report(s) | International search report - published on: | EP | 01.09.2016 | Classification | IPC: | C12N15/09 | [2018/01] | CPC: |
C07K16/00 (EP,CN,US);
C12N15/85 (KR,US);
C12N15/09 (EP,CN,US);
C07K1/18 (KR);
C07K1/22 (KR);
C12N5/0602 (KR);
C12N9/18 (KR);
C12N9/20 (EP,US);
C07K2317/14 (EP,CN,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/01] | Extension states | BA | 14.08.2017 | ME | 14.08.2017 | Validation states | MA | 14.08.2017 | MD | 14.08.2017 | Title | German: | WIRTSZELLENPROTEINMODIFIKATION | [2018/01] | English: | HOST CELL PROTEIN MODIFICATION | [2018/01] | French: | MODIFICATION DE PROTÉINES DE CELLULES HÔTES | [2018/01] | Entry into regional phase | 14.08.2017 | National basic fee paid | 14.08.2017 | Designation fee(s) paid | 14.08.2017 | Examination fee paid | Examination procedure | 14.08.2017 | Amendment by applicant (claims and/or description) | 14.08.2017 | Examination requested [2018/01] | 14.08.2017 | Date on which the examining division has become responsible | 04.06.2018 | Despatch of a communication from the examining division (Time limit: M06) | 14.12.2018 | Reply to a communication from the examining division | 01.02.2019 | Communication of intention to grant the patent | 10.06.2019 | Fee for grant paid | 10.06.2019 | Fee for publishing/printing paid | 10.06.2019 | Receipt of the translation of the claim(s) | Opposition(s) | Opponent(s) | 01
21.05.2020
25.05.2020
ADMISSIBLE Dr. H. Ulrich Dörries Fünf Höfe, Theatinerstr. 16 80333 München / DE Opponent's representative Dörries, Hans Ulrich df-mp Fünf Höfe Theatinerstrasse 16 80333 München / DE | [2020/27] | 16.06.2020 | Invitation to proprietor to file observations on the notice of opposition | 26.11.2020 | Reply of patent proprietor to notice(s) of opposition | 01.12.2020 | Despatch of communication that the patent will be revoked | 11.12.2020 | Legal effect of revocation of patent [2021/16] | Fees paid | Renewal fee | 22.02.2018 | Renewal fee patent year 03 | 20.02.2019 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 21.08.2019 | AT | 21.08.2019 | CY | 21.08.2019 | EE | 21.08.2019 | FI | 21.08.2019 | HR | 21.08.2019 | LT | 21.08.2019 | LV | 21.08.2019 | MC | 21.08.2019 | MK | 21.08.2019 | PL | 21.08.2019 | RO | 21.08.2019 | RS | 21.08.2019 | SI | 21.08.2019 | SK | 21.08.2019 | SM | 21.08.2019 | TR | 21.08.2019 | BG | 21.11.2019 | GR | 22.11.2019 | IS | 21.12.2019 | PT | 23.12.2019 | LU | 26.02.2020 | [2024/30] |
Former [2022/32] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
MC | 21.08.2019 | ||
MK | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
SI | 21.08.2019 | ||
SK | 21.08.2019 | ||
SM | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
LU | 26.02.2020 | ||
Former [2020/50] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
MC | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
SI | 21.08.2019 | ||
SK | 21.08.2019 | ||
SM | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
LU | 26.02.2020 | ||
Former [2020/48] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
SI | 21.08.2019 | ||
SK | 21.08.2019 | ||
SM | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
LU | 26.02.2020 | ||
Former [2020/37] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
SI | 21.08.2019 | ||
SK | 21.08.2019 | ||
SM | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
Former [2020/36] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
SK | 21.08.2019 | ||
SM | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
Former [2020/27] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
SK | 21.08.2019 | ||
SM | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
PT | 23.12.2019 | ||
IS | 24.02.2020 | ||
Former [2020/25] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
SK | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
PT | 23.12.2019 | ||
IS | 24.02.2020 | ||
Former [2020/24] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
PT | 23.12.2019 | ||
IS | 24.02.2020 | ||
Former [2020/23] | AL | 21.08.2019 | |
AT | 21.08.2019 | ||
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
PL | 21.08.2019 | ||
RO | 21.08.2019 | ||
RS | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
Former [2020/22] | AL | 21.08.2019 | |
EE | 21.08.2019 | ||
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
RS | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
Former [2020/17] | AL | 21.08.2019 | |
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
RS | 21.08.2019 | ||
TR | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
Former [2020/15] | AL | 21.08.2019 | |
FI | 21.08.2019 | ||
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
RS | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
Former [2020/12] | FI | 21.08.2019 | |
HR | 21.08.2019 | ||
LT | 21.08.2019 | ||
LV | 21.08.2019 | ||
RS | 21.08.2019 | ||
BG | 21.11.2019 | ||
GR | 22.11.2019 | ||
IS | 21.12.2019 | ||
PT | 23.12.2019 | ||
Former [2020/10] | FI | 21.08.2019 | |
LT | 21.08.2019 | ||
BG | 21.11.2019 | ||
PT | 23.12.2019 | ||
Former [2020/09] | FI | 21.08.2019 | |
LT | 21.08.2019 | ||
Former [2020/08] | LT | 21.08.2019 | Cited in | International search | [XY] - KIM DAESOO ET AL, "Phospholipase C isozymes selectively couple to specific neurotransmitter receptors", NATURE (LONDON), (1997), vol. 389, no. 6648, ISSN 0028-0836, pages 290 - 293, XP002757066 [X] 1-12 * the whole document * [Y] 13-24 DOI: http://dx.doi.org/10.1038/38508 | [XY] - KURIAN MANJU A ET AL, "Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy", BRAIN, (201010), vol. 133, no. Part 10, pages 2964 - 2970, XP002757067 [X] 1-12 * the whole document * [Y] 13-24 DOI: http://dx.doi.org/10.1093/brain/awq238 | [X] - BOGARAPU SOUJANYA ET AL, "Phenotype of a Patient With Contiguous Deletion of TBX5 and TBX3: Expanding the Disease Spectrum", AMERICAN JOURNAL OF MEDICAL GENETICS, (201405), vol. 164, no. 5, pages 1304 - 1309, XP002757068 [X] 1-24 * the whole document * DOI: http://dx.doi.org/10.1002/ajmg.a.36447 | [A] - BRUNTZ RONALD C ET AL, "Phospholipase D Signaling Pathways and Phosphatidic Acid as Therapeutic Targets in Cancer", PHARMACOLOGICAL REVIEWS, (201410), vol. 66, no. 4, pages 1033 - 1079, XP002757069 [A] 1-24 * the whole document * DOI: http://dx.doi.org/10.1124/pr.114.009217 | by applicant | US7771997 | - SCHENAUER, MR. ET AL., BIOTECHNOL PROG, (2013), vol. 29, no. 4, pages 951 - 957 | - TAIT ET AL., BIOTECHNOL PROG, (2013), vol. 29, no. 3, pages 688 - 696 | - LABRENZ, S.R., "Ester hydrolysis of polysorbate 80 in mAb drug product: evidence in support of the hypothesized risk after observation of visible particulate in mAb formulations", J. PHARMA. SCI., (2014), vol. 103, no. 8, doi:doi:10.1002/jps.24054, pages 2268 - 77, XP055514263 DOI: http://dx.doi.org/10.1002/jps.24054 | - UPTON, C; BUCKLEY, JT, "A new family of lipolytic enzymes?", TRENDS BIOCHEM SCI., (1995), vol. 20, doi:doi:10.1016/S0968-0004(00)89002-7, pages 178 - 179, XP004222260 DOI: http://dx.doi.org/10.1016/S0968-0004(00)89002-7 | - REPO, H. ET AL., PROTEINS, (2014), vol. 82, pages 300 - 311 | - KANOH, H. ET AL., COMP BIOCHEM PHYSIOL, (1991), vol. 102B, no. 2, pages 367 - 369 | - BOCH J ET AL., SCIENCE, (2009), vol. 326, pages 1509 - 1512 | - BOGDANOVE, A. J.; VOYTAS, D. F., SCIENCE, (2011), vol. 333, pages 1843 - 1846 | - MILLER, J. C. ET AL., NAT BIOTECHNOL, (2011), vol. 29, pages 143 - 148 | - STELLA, S. ET AL., ACTA CRYST., (2014), vol. D70, pages 2042 - 2052 | - METH. ENZYMOLOGY, (1988), vol. 185, page 537 | - WIGLER ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, page 3567 | - SCHAFFNER ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, page 2163 | - POTTER ET AL., PROC. NATL. ACAD. SCI. USA, (1988), vol. 81, page 7161 | - SHIGEKAWA ET AL., BIOTECHNIQUES, (1988), vol. 6, page 742 | - SAMBROOK, Molecular Biology: A Laboratory Manual, COLD SPRING HARBOR LABORATORY, (1989), pages 16.9 - 16.14 | Opposition | US15055034 | WO2015038888 | WO2015095568 | - WANG X et al., "Host cell proteins in biologics development: Identification, quantitation and risk assessment", Biotechnology and Bioengineering, vol. 103, no. 3, (20090400), pages 446 - 458, XP002546192 DOI: http://dx.doi.org/10.1002/BIT.22304 | - HOGWOOD C E M et al., "Measurement and control of host cell proteins (HCPs) in CHO cell bioprocesses", Current Opinion in Biotechnology, (20141200), vol. 30, pages 153 - 160, XP055378440 DOI: http://dx.doi.org/10.1016/j.copbio.2014.06.017 | - VALENTE K et al., "Expression of Difficult-to-Remove Host Cell Protein Impurities During Extended Chinese Hamster Ovary Cell Culture and Their Impact on Continuous Bioprocessing", Biotechnology and Bioengineering, vol. 112, no. 6, (20150116), pages 1232 - 1242, XP002796221 DOI: http://dx.doi.org/10.1002/bit.25515 | - JOUCLA G et al., "Cation exchange versus multimodal cation exchange resins for antibody capture from CHO supernatants: Identification of contaminating Host Cell Proteins by mass spectrometry", J of Chromatography B, (20131200), vol. 942-943, pages 126 - 133, XP028788271 DOI: http://dx.doi.org/10.1016/j.jchromb.2013.10.033 | - ABOULAICH N et al., "A novel approach to monitor clearance of host cell proteins associated with monoclonal antibodies", Biotechnol Prog., vol. 30, no. 5, (20140700), pages 1114 - 1124, XP055425286 DOI: http://dx.doi.org/10.1002/btpr.1948 | - RONDA C et al., "Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool", Biotechnology and Bioengineering, (20140800), vol. 111, no. 8, pages 1604 - 1616, XP055244605 DOI: http://dx.doi.org/10.1002/bit.25233 | - BRINKROLF K et al., "Chinese hamster genome sequenced from sorted chromosomes", Nature Biotechnology, (20130000), vol. 31, pages 694 - 695, XP055721392 DOI: http://dx.doi.org/10.1038/nbt.2645 | - XU X et al., "The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line", Nature Biotechnology, (20110000), vol. 29, no. 8, pages 735 - 742, XP055223996 DOI: http://dx.doi.org/10.1038/nbt.1932 | - GAO S X et al., "fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity", Biotechnology and Bioengineering., (20110000), vol. 2011, no. 4, pages 977 - 982, XP055721400 DOI: http://dx.doi.org/10.1002/bit.22982 | - VANDERLAAN M, "hamster phospholipase B-like 2 (PLBL2) A host cell protein impurity in cho-derived therapeutic monoclonal antibodies", CaSSS CMC Strategy Form, Washington DC, (20150125), XP055337487 | - LEVY N, "Host cell protein impurities and protein-protein interactions in downstream purification of monoclonal", Dissertation, (20141100), XP055682644 DOI: http://dx.doi.org/10.1002/bit.25882 | - VANDERLAAN M et al., "Polyurethanes from ALCELL LIGNIN", Bioprocess International, (20150414), vol. 13, no. 14, pages 18 - 25, XP002720465 DOI: http://dx.doi.org/10.1016/S0961-9534(97)00030-5 | - HANANIA N A et al., "lebrikizumab in moderate to servere asthma pooled data from two randomised placebo controlled studies", Thorax, vol. 70, no. 8, (20150500), pages 748 - 56, XP055721414 |